The Enterprise Value as of December 2025 (TTM) for BCAL Diagnostics Limited (BDX.AX) is 34.64M

According to BCAL Diagnostics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 34.64M. This represents a change of 52.87% compared to the average of 22.66M of the last 4 quarters.

BCAL Diagnostics Limited (BDX.AX) Historical Enterprise Value (quarterly & annually)

How has BDX.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of BCAL Diagnostics Limited over the last ten years is 35.62M. The current 34.64M Enterprise Value has changed 9.62% with respect to the historical average. Over the past ten years (40 quarters), BDX.AX's Enterprise Value was at its highest in in the June 2018 quarter at 53.97M. The Enterprise Value was at its lowest in in the December 2017 quarter at 0.

BCAL Diagnostics Limited (BDX.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BCAL Diagnostics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BCAL Diagnostics Limited (BDX.AX) Average Enterprise Value

How has BDX.AX Enterprise Value performed in the past?

The current Enterprise Value of BCAL Diagnostics Limited (BDX.AX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

BCAL Diagnostics Limited (BDX.AX) Enterprise Value vs. Peers

How is BDX.AX’s Enterprise Value compared to its peers?

BCAL Diagnostics Limited’s Enterprise Value is greater than Microba Life Sciences Limited (25.07M), greater than INOVIQ Ltd (32.64M), greater than Rhythm Biosciences Limited (23.13M), greater than Argenica Therapeutics Limited (21.56M), greater than Noxopharm Limited (29.86M), less than Nova Eye Medical Limited (37.84M), greater than HeraMED Limited (16.14M), greater than Emyria Limited (29.77M), greater than Atomo Diagnostics Limited (23.70M), greater than IDT Australia Limited (32.25M),

Build a custom stock screener for BCAL Diagnostics Limited (BDX.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BCAL Diagnostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BCAL Diagnostics Limited (BDX.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BCAL Diagnostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.